Novavax ’s Coronavirus Vaccine Enters Late-Stage Trials

Novavax received $1.6 billion from the U.S. federal government to fund the late-stage development and production of its vaccine.

Source: Forbes.com Healthcare News - September 24, 2020 Category: Pharmaceuticals Authors: Elana Lyn Gross, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus Billionaires Source Type: news